08 Dec 2022 --- In scrutiny of the US Food and Drug Administration’s (FDA) Human Food Program, an independent expert panel is arguing that the agency “lacks the resources and authority to do what is expected to do – ensure the safety and availability of food on the market.” In response, the FDA has underlined the pressures it currently faces, which includes supply chain disruptions and the challenge of screening “rapid advancements” in food science.
